Table 1: Fibroid dimensions and volume before and after embolization (N=34)

* Statistically significant (p<.0001) mean difference on paired t-test

UFS-QOL scale	baseline	after uUAE	pre/post difference/reduction

	M (SD)	M (SD)	Difference (95%CI)
Severity	53.7 (26)	29.8 (21.3)	35.6 (8.9, 62.3)*
Concern	39.5 (34)	24.2 (24.7)	29.4 (6.2, 52.5)*
Activities	36.3 (31.7)	20.7 (30.3)	30.7 (5.6, 55.7)*
Energy/mood	39.3 (32.1)	10.7 (17.5)	37.1 (11.6, 62.7)*
Control	38.6 (29.5)	13.7 (22.9)	28.1 (2.7, 53.6)*
Self-concious	40.2 (36.7)	30.7 (26.2)	20.8 (-7.8, 49.4)
Sexual function	42 (37.2)	21.2 (29)	31.3 (0.1, 62.4)*
HRQOL total score	39.3 (27.9)	19.5 (18.5)	29.6 (6.6, 52.5)*

Table 2: Mean UFS-QOL scores at baseline and 3 months after uUAE (N=34). Lower scores indicate better quality of life

* Statistically significant (p<.05) mean difference on paired t-test.

Table 1

Table 2

Figure 1

Figure 2

Figure 1: Individual change (grey) and mean change (black) in fibroid volume before and after embolization

Figure 2: Number of patients with particular infarction rate (N=34, Median = 100, Interquartile range = 50 to 100)